Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars ---
Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division
Ingredion Completes Reorganization, Reports First Quarter Earnings Under New Segments and Raises Guidance
Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs
Descartes’ Annual Ecommerce Study Shows Online Buying Grows but 67% of Consumers Face Delivery Problems